Virtu Financial’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Virtu Financial’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,383	Closed	-$2K	–	2151
2025 Q3	$2K	Buy	+20,383	New	+$909	﹤0.01%	1388
2025 Q2	–	Sell	-16,100	Closed	-$1K	–	1976
2025 Q1	$1K	Buy	+16,100	New	+$2.33K	﹤0.01%	1272
2023 Q1	–	Sell	-13,091	Closed	-$13K	–	2023
2022 Q4	$13K	Buy	+13,091	New	+$11.2K	﹤0.01%	1345
2021 Q2	–	Sell	-14,169	Closed	-$7K	–	1997
2021 Q1	$7K	Buy	+14,169	New	+$9.13K	﹤0.01%	1530

Virtu Financial's RVPHW Position: Q4 2025 in Review

Virtu Financial sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q4 2025, closing a stake of 20,383 shares — an estimated $2K sold.

Virtu Financial first reported a position in RVPHW in Q1 2021 and held it in 4 quarters. The position peaked at $13K in Q4 2022. 0 funds tracked by Wall St. Rank hold RVPHW as of Q4 2025.

Virtu Financial reported no remaining Reviva Pharmaceuticals Warrants position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 20,383 Reviva Pharmaceuticals Warrants shares in Q4 2025, an estimated $2K.
Virtu Financial first reported a position in Reviva Pharmaceuticals Warrants in Q1 2021 and held it in 4 quarters.
Virtu Financial's Reviva Pharmaceuticals Warrants position peaked at $13K in Q4 2022.
0 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.